Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Medical Imaging Techniques and Applications.
Effects of α‐synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease
Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathy
Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging
Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease
The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort
Novel modelling approaches to elucidate the genetic architecture of resilience to Alzheimer’s disease
A Novel Method in PET Image Reconstruction Using MRI Anatomical Priors
Deep Learning-Based Prediction of PET Amyloid Status Using MRI.
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Effects of α-synuclein pathology in normal aging and Alzheimer’s disease
Association of types of cognitive and social activities with cognitive performance and Alzheimer's disease biofluid biomarkers: an examination of cognitively normal adults in the Stanford Aging and Memory Study (SAMS)
Speech patterns during memory recall relates to early tau burden across adulthood
A 3'UTR Insertion Is a Candidate Causal Variant at the <i>TMEM106B</i> Locus Associated With Increased Risk for FTLD-TDP.
Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation.
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Patterns of Tau Deposition by Cognitive Subtype in the Alzheimer's Disease Neuroimaging Initiative
Genetic and Sex Associations with Earlier Estimated Onset of Amyloid Positivity from over 4000 Harmonized Positron Emission Tomography Images
Association of lifestyle activities with cognitive function and Alzheimer’s disease CSF biomarkers: an examination of cognitively normal adults in the Stanford Aging and Memory Study (SAMS)
Organ aging signatures in the plasma proteome track health and disease
APOE effects on regional tau in preclinical Alzheimer’s disease
Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
Reductions in synaptic marker SV2A in early-course Schizophrenia
Generative Adversarial Network-Enhanced Ultra-Low-Dose [<sup>18</sup>F]-PI-2620 τ PET/MRI in Aging and Neurodegenerative Populations.
Charting the genetic architecture of Alzheimer’s disease across APOE*4 and sex
Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease
Tau positron emission tomography in preclinical Alzheimer’s disease
Machine learning based multi-modal prediction of future decline toward Alzheimer’s disease: An empirical study